Avitriptan (BMS-180048), a new 5-HT 1B/1D receptor agonist, has been studied in phase II clinical trials in patients with migraine headaches. Reference standards of Avitriptan API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
1-(3-(3-(4-(5-Methoxypyrimidin-4-yl)piperazin-1-yl)propyl)-1H-indol-5-yl)-N-methylmethanesulfonamide
Catalogue No.:PA 01 3290000
CAS :
Molecular Formula : C22H30N6O3S
Molecular Weight : 458.58
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
